Pharmacy research: driving safer outcomes in substance misuse Research offers a crucial opportunity in shaping healthcare policy and practice, particularly in the developing landscape of substance misuse.…
Health news round-up: Alzheimer’s treatment, retatrutide results and kidney cancer guidelines A weekly summary of important developments in pharmacy and health news that you may have missed.…
It is ‘vital’ that patients access weight-loss jabs from pharmacies, says London health committee A report by the London Assembly Health Committee recommended strict safeguards to ensure that only the eligible can purchase weight-loss drugs, as well as comprehensive wrap-around care for patients.…
London’s first drug-checking service could expand to more cities Under the drug-checking service, users can submit substances for testing and will subsequently receive “anonymous, non-judgemental chat”, alongside tailored harm reduction advice.…
Government pledges support for more safer drug consumption facilities in ten-year alcohol and drug strategy The Scottish government's alcohol and drugs strategic plan for 2026–2035 also sets out plans to further expand the distribution of naloxone, including through community pharmacies.…
Health news round-up: puberty blockers, oral GLP-1s and inequalities in neonatal care A weekly summary of important developments in pharmacy and health news that you may have missed.…
Orforglipron offers greater weight loss for people with diabetes than oral semaglutide Researchers found that although patients who took orforglipron lost more body weight on average compared with semaglutide, more patients stopped taking the drug owing to adverse effects.…
Pharmacies respond to GP funding incentives for weight-loss drugs The government said that two indicators that track the provision of obesity care to eligible patients will be added to the Quality and Outcomes Framework under the GP contract for 2026/2027.…
Health news round-up: GLP-1s for psoriasis, promise for people with cancer and pharmacogenomics A weekly summary of important developments in pharmacy and health news that you may have missed.…
NICE widens access to SGLT-2 inhibitors and GLP-1s in updated type 2 diabetes guidance The National Institute for Health and Care Excellence said the changes could prevent up to 17,000 deaths in the UK over three years.…
